News Shingles vaccine boosts GSK as generic Advair bites GSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of declining Advair sales.
News FDA approves first treatment for children with lupus The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus.
News Fulcrum repurposes failed GSK drug for rare disease GSK’s failed cardiovascular drug losmapimod looks like it might get a new lease of life after being picked up by biotech Fulcrum Therapeutics, who want to repurpose the drug to treat the ra
Views & Analysis Rethinking drug discovery George Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change.
Views & Analysis Pharma’s apprentice army is sculpting the future A skills gap has been threatening to knock the shine off the UK biotechnology sector’s sparkling reputation for the last few years.
Sales & Marketing Q4 results roundup 2019 With the full year results season drawing to a close, Richard Staines asks who the winners were and who has been left playing catch-up.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.